Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV

被引：14
|
作者：
Zhang, Hang [2 ]
Wu, Lian-Ying [1 ]
Zhang, Shuai [2 ]
Qiu, Li-Yan [2 ]
Li, Nan [2 ]
Zhang, Xuan [2 ]
Zhang, Xue-Zhi [2 ]
Shan, Chang-Liang [2 ]
Ye, Li-Hong [1 ]
Zhang, Xiao-Dong [2 ]
机构：
[1] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China
[2] Nankai Univ, Coll Life Sci, Inst Mol Biol, Minist Educ,Dept Canc Res,Key Lab Mol Microbiol &, Tianjin 300071, Peoples R China
来源：
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2009年
关键词：
HEPATOCELLULAR-CARCINOMA; MONOCLONAL-ANTIBODY; INFECTION; DNA; IDENTIFICATION; INTEGRATION; EXPRESSION; CARRIERS; EPITOPE; LEVEL;
D O I：
10.1155/2009/289068
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Hepatitis B virus X protein (HBx) plays a crucial role in the development of hepatocellular carcinoma (HCC). However, the significance of circulating antibody to hepatitis B virus X antigen (anti-HBx) in sera remains unclear. In the present study, we examined the titers of anti-HBx (IgG) in the sera from 173 patients with chronic hepatitis B (CHB), 106 liver cirrhosis (LC), and 61 HCC by enzyme-linked immunosorbent assay (ELISA), respectively. Our data showed that the positive rates of anti-HBx were higher in sera of LC (40.6%) and HCC (34.4%) than those of CHB (10.4%), P < .05. In all 40 patients with anti-HBx+ out of 340 patients, 39 (97.5%) were HBsAg/HBeAg/anti-HBc+ and 1 (2.5%) was anti-HBs+ (P < .01), suggesting that anti-HBx in sera is a marker of HBV replication rather than a protective antibody. Thus, our findings reveal that circulating anti-HBx in sera is one of the markers of development of LC and HCC mediated by HBV. Copyright (C) 2009 Hang Zhang et al.
引用
收藏
页数：6
相关论文
共 50 条
  • [11] Multiple Diagnostic Indicators in the Development of Chronic Hepatitis B, Liver Cirrhosis, and Liver Cancer
    Yang, Chao
    Geng, Huijuan
    Zhu, Shanshan
    Zheng, Xiaomeng
    Li, Tiemin
    Duan, Lin
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (03) : 153 - 159
  • [12] Hepatitis B virus X protein in liver tumor microenvironment
    Fu, Sha
    Zhou, Rong-rong
    Li, Ning
    Huang, Yan
    Fan, Xue-Gong
    TUMOR BIOLOGY, 2016, 37 (12) : 15371 - 15381
  • [13] Absence of anti-hepatitis B virus (HBV) core in HIV/HBV coinfection with advanced immunosuppression
    Avelino-Silva, V. I.
    Miraglia, J. L.
    Gomes-Gouvea, M. S.
    Pinho, J. R. R.
    Mendes-Correa, M. C.
    HIV MEDICINE, 2013, 14 (07) : 453 - 454
  • [14] A QSAR study on some series of anti-hepatitis B virus (HBV) agents
    Arora, Preet K.
    Patil, Vaishali M.
    Gupta, Satya P.
    BIOINFORMATION, 2010, 4 (09) : 417 - 420
  • [15] Gene expression profiles of human liver cells mediated by hepatitis B virus X protein
    Wei-ying Zhang
    Fu-qing Xu
    Chang-liang Shan
    Rong Xiang
    Li-hong Ye
    Xiao-dong Zhang
    Acta Pharmacologica Sinica, 2009, 30 : 424 - 434
  • [16] Gene expression profiles of human liver cells mediated by hepatitis B virus X protein
    Zhang, Wei-ying
    Xu, Fu-qing
    Shan, Chang-liang
    Xiang, Rong
    Ye, Li-hong
    Zhang, Xiao-dong
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (04) : 424 - 434
  • [17] Impact of the Timing of Hepatitis B Virus Identification and Anti-Hepatitis B Virus Therapy Initiation on the Risk of Adverse Liver Outcomes for Patients Receiving Cancer Therapy
    Hwang, Jessica P.
    Suarez-Almazor, Maria E.
    Cantor, Scott B.
    Barbo, Andrea
    Lin, Heather Y.
    Ahmed, Sairah
    Chavez-MacGregor, Mariana
    Donato-Santana, Christian
    Eng, Cathy
    Ferrajoli, Alessandra
    Fisch, Michael J.
    McLaughlin, Peter
    Simon, George R.
    Rondon, Gabriela
    Shpall, Elizabeth J.
    Lok, Anna S.
    CANCER, 2017, 123 (17) : 3367 - 3376
  • [18] HEPATITIS B-VIRUS AND PRIMARY LIVER CARCINOMA - EVIDENCES FOR A FILIATION HEPATITIS-B, CIRRHOSIS AND PRIMARY LIVER CANCER
    MAUPAS, P
    COURSAGET, P
    GOUDEAU, A
    DRUCKER, J
    SANKALE, M
    LINHARD, J
    DIEBOLT, G
    ANNALES DE MICROBIOLOGIE, 1977, A128 (02): : 245 - 253
  • [19] ALCOHOLIC CIRRHOSIS OF THE LIVER AND HEPATITIS-B VIRUS
    ARON, E
    BOUGNOUX, P
    DUBOIS, F
    GOUDEAU, A
    COURSAGET, P
    MAUPAS, P
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1978, 162 (09): : 848 - 853
  • [20] The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    Perz, Joseph F.
    Armstrong, Gregory L.
    Farrington, Leigh A.
    Hutin, Yvan J. F.
    Bell, Beth P.
    JOURNAL OF HEPATOLOGY, 2006, 45 (04) : 529 - 538
12345